Hongyong He
Overview
Explore the profile of Hongyong He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1027
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Min L, Lu J, He H
Ann Med Surg (Lond)
. 2024 Nov;
86(11):6440-6446.
PMID: 39525752
Background: This study aimed to analyze the clinical data of patients who received conservative treatment for acute complicated appendicitis with peri-appendiceal abscess, identify factors influencing the success rate, and improve...
2.
Gu Y, Sun M, Fang H, Shao F, Lin C, Liu H, et al.
Br J Cancer
. 2024 Aug;
131(8):1320-1327.
PMID: 39217196
Background: This study aimed to reveal the effect of TP53 status on clinical outcomes and underlying mechanism in gastric cancer (GC) patients. Methods: TP53 status was divided into three groups...
3.
Sun M, Gu Y, Fang H, Shao F, Lin C, Zhang H, et al.
Cancer Sci
. 2023 Dec;
115(3):905-915.
PMID: 38148578
Chromatin remodelers are commonly altered in human cancer. The mutation of AT-rich interactive domain 1A (ARID1A) in gastric cancer (GC), a component of the SWI/SNF chromatin remodeling complex, was proven...
4.
Lv K, Sun M, Fang H, Wang J, Lin C, Liu H, et al.
J Immunother Cancer
. 2023 Nov;
11(11).
PMID: 37935567
Objective: Immunotherapy has not yielded satisfactory therapeutic responses in gastric cancer (GC). However, targeting myeloid checkpoints holds promise for expanding the potential of immunotherapy. This study aims to evaluate the...
5.
Liu X, Lv K, Wang J, Lin C, Liu H, Zhang H, et al.
Br J Cancer
. 2023 Jul;
129(4):721-732.
PMID: 37422529
Background: This study aimed to investigate the expression and clinical significance of Dendritic cell-associated C-type lectin-1 (Dectin-1) in gastric cancer (GC), and to explore the mechanism of Dectin-1 regulating tumour-associated...
6.
He H, Lin C, Li R, Zang L, Huang X, Liu F
Int J Surg
. 2023 May;
109(8):2179-2184.
PMID: 37158145
Background: This study was designed to investigate incidences of surgeons' mental distress following severe complications after radical gastrectomy. Methods: A cross-sectional survey was conducted between 1 June 2021 and 30...
7.
Zhang P, Gu Y, Wang J, Lv K, Lin C, Zhang H, et al.
Int J Cancer
. 2023 Feb;
153(1):224-237.
PMID: 36799619
In gastric cancer (GC), the therapeutic response of immune checkpoint blockade (ICB) remains suboptimal. Targeting myeloid cell checkpoints might be feasible as adjuvant to current ICB regimens. We sought to...
8.
Gu Y, Zhang P, Wang J, Lin C, Liu H, Li H, et al.
Cancer Immunol Immunother
. 2022 Nov;
72(5):1199-1208.
PMID: 36369379
Background: AT-rich interaction domain 1A (ARID1A) encodes a vital component of switch/sucrose non-fermentable chromatin-remodeling complex. Given its association with genomic instability, we conducted this study to determine whether ARID1A mutation...
9.
Yu K, Gu Y, Zhang P, Fang H, Cao Y, Wang J, et al.
Br J Cancer
. 2022 Aug;
127(9):1709-1717.
PMID: 36002752
Background: Although PD-1 has been reported to be a marker of T-cell exhaustion in several malignancies, the biological role of PD-1CD8 T cells in gastric cancer (GC) remains unclear. Herein,...
10.
Xu C, Fang H, Gu Y, Yu K, Wang J, Lin C, et al.
Cancer Sci
. 2022 Aug;
113(12):4070-4081.
PMID: 35997524
CD96 was identified as a novel immune checkpoint. However, the role of CD96 in the gastric cancer (GC) microenvironment remains fragmentary. This study aimed to probe the clinical significance of...